Scope

The intended scope for the Canadian Clinical Drug Data Set (CCDD) is to include medicinal products (including immunizing agents), over-the-counter products, natural health products and a limited number of medical devices for human use within Canada in the following files:

  1. The Non-proprietary Therapeutic Product (NTP) file contains brand independent and clinically oriented representations of manufactured (therapeutic) products.    This includes combination products, which for the purpose of CCDD means products with more than one component, such as kits: 
  2. The Device Non-proprietary Therapeutic Product (Device-NTP) file contains brand independent and clinically oriented representations of manufactured devices.  This includes only a small number of devices (such as lancets, glucose meters and blood glucose strips) that are prescribed by a community clinician and dispensed in a pharmacy.
  3. The Therapeutic Moiety (TM) file, contains concepts that describe the functional and clinically significant part of the active ingredient substance(s) present in a medicinal product without reference to strength and dose form. 
  4. The file containing Manufactured Product (MP) contains descriptions of the brand specific drug that are available for clinical use in Canada.  
  5. Relationship files that describe the associations between the NTP concepts, MP concepts and TM concepts: 
    • One relationship file with the English formal name and codes and a separate relationship file with French descriptions and codes.
  6. The Special Groupings file identifies specific concepts in the Canadian Clinical Drug Data Set and provides relationships between those concepts and policies (such as controlled substances) that apply to those products:
  7. The Coded Attributes file provides the coded values used in an attribute field within the Canadian Clinical Drug Data Set.

The current scope of content within CCDD, driven by relevance to e-prescribing and to some extent medication profiles, has been modified from the intended scope as follows:

  • Immunizing agents are currently under development for inclusion in the data set, and therefore not currently in CCDD.
  • Products present in the Licensed Natural Health Products Database (LNHPD) are out of scope for now
  • Currently the following types of products are out of scope with the expectation that a stakeholder use case would be required prior to considering addition to CCDD:
    • Highly specialized hospital use products that might not be prescribed in the usual manner for medications and/or are unlikely to be included on a Patient Profile, including:

o   dialysis and hemofiltration fluids

o   large volume intravenous fluids

o   parenteral nutrition products

o   antidotes for poisoning

o   allergens for sensitivity testing

o   imaging products (x-ray contrast media, etc.)

o   antiseptics used for skin cleansing

    • General care products

      o   Sunscreens

      o   Disinfectants

      o   Products whose primary use is cosmetic

  • No labels